Drug Overview

Axitinib is a powerful “Smart Drug” used to treat advanced kidney cancer. It belongs to a group of medicines called Targeted Therapy. Unlike older treatments that affect the whole body, this medicine focuses on the specific signals that help tumors grow and spread.

Generic Name: Axitinib.
US Brand Names: Inlyta.
Drug Class: Tyrosine Kinase Inhibitor (TKI); Vascular Endothelial Growth Factor (VEGF) Receptor Inhibitor.
Route of Administration: Oral (Tablets taken by mouth).
FDA Approval Status: FDA Approved for advanced renal cell carcinoma (kidney cancer).

What Is It and How Does It Work? (Mechanism of Action)

Axitinib is designed to cut off the “food supply” to a tumor. It works at a deep molecular level to stop a process called angiogenesis, which is how tumors grow their own blood vessels.

Molecular Targeting (VEGF Receptors)

Cancer cells send out “help signals” to the body to request more blood and nutrients. These signals are proteins called Vascular Endothelial Growth Factor (VEGF). On the surface of blood vessel cells, there are “receivers” called VEGF Receptors (1, 2, and 3).

Blocking the Signal

When the signal (VEGF) hits the receiver (Receptor), it normally tells the cell to build a new blood vessel. Axitinib works by getting inside the cell and blocking the “engine” of these receivers (the Tyrosine Kinase).

The Result: Because the “engine” is blocked, the message to build new blood vessels never gets through.
Tumor Starvation: Without new blood vessels, the tumor cannot get the oxygen and food it needs to grow. This causes the tumor to shrink or stop growing entirely.

FDA Approved Clinical Indications

Axitinib is primarily used to treat cancer of the kidneys. It can be used alone or in combination with other modern medicines.

Oncological Uses:
- Advanced Renal Cell Carcinoma (RCC): Used as a second-line treatment after one previous medicine has failed.
- First-Line Treatment for RCC: Used in combination with Immunotherapy drugs (like pembrolizumab or avelumab) for patients who have not yet received any treatment.
Non-oncological Uses:
- None at this time.

Dosage and Administration Protocols

Axitinib is a pill taken twice a day. Doctors may change the dose based on how well the patient handles the medicine.

Regimen Type	Standard Starting Dose	Frequency	Timing
Monotherapy	5 mg	Twice daily	12 hours apart
Combination Therapy	5 mg	Twice daily	12 hours apart
Dose Increase	Up to 7 mg or 10 mg	Twice daily	Based on safety/tolerance
Dose Decrease	3 mg or 2 mg	Twice daily	Based on side effects

Dose Adjustments:

Hepatic (Liver) Insufficiency: Patients with moderate liver issues should start at a lower dose (usually 2 mg twice daily). It is not recommended for patients with severe liver failure.
Renal (Kidney) Insufficiency: No starting dose adjustment is needed for patients with kidney issues.

Clinical Efficacy and Research Results

Recent studies from 2020 to 2025 have shown that Axitinib is very effective when paired with other new therapies.

Combination Efficacy: In trials like KEYNOTE-426, using Axitinib with pembrolizumab (an immunotherapy) reduced the risk of death by nearly 47% compared to older drugs.
Survival Rates: Research shows that the 24-month Overall Survival rate was approximately 74% for patients on the combination therapy.
Progression-Free Survival: Patients taking this drug combination lived for a median of 15 to 16 months without their cancer getting worse, which is a major improvement over previous standards.

Safety Profile and Side Effects

While Axitinib is a targeted treatment, it can still cause side effects because VEGF receptors are found in some healthy parts of the body, like the skin and heart.

Warning: Axitinib can cause high blood pressure (hypertension). This must be checked and managed before starting the medicine.

Common Side Effects (>10%)

Diarrhea: Very common and can lead to dehydration.
High Blood Pressure: This is a sign the drug is active in the body.
Fatigue: Feeling very tired or weak.
Nausea and Vomiting.
Hand-Foot Syndrome: Redness, swelling, or pain on the palms of the hands and soles of the feet.
Voice Changes: Hoarseness or a raspy voice.

Serious Adverse Events

Blood Clots: Such as deep vein thrombosis (DVT) or heart attack.
Bleeding Issues: Including nosebleeds or internal bleeding.
Hole in the Stomach/Intestine: Known as gastrointestinal perforation.
Protein in Urine: A sign of kidney stress.

Management Strategies

Blood Pressure Monitoring: Patients should check their blood pressure at home every day.
Anti-diarrheal Medicine: Over-the-counter medicine (like loperamide) is often used at the first sign of loose stools.
Skin Cream: Thick, unscented moisturizers help prevent hand-foot syndrome.

Research Areas

Axitinib is currently being studied in new “Regenerative Medicine” and “Immunotherapy” trials. Researchers are looking at how this drug can be used in smaller doses alongside Cancer Vaccines to make the tumor more vulnerable. There is also research into using Axitinib to treat other types of solid tumors, such as liver cancer and advanced thyroid cancer, by combining it with different types of immune-boosting therapies.

Patient Management and Practical Recommendations

Pre-treatment Tests

Blood Pressure Check: Must be controlled before the first dose.
Urine Test: To check for protein levels.
Thyroid Test: To ensure your thyroid is working correctly.

Precautions During Treatment

Avoid Grapefruit: Grapefruit and grapefruit juice can increase the amount of medicine in your blood to a dangerous level.
Surgery: You may need to stop taking Axitinib for a few days before and after any surgery or dental work to help your body heal.

“Do’s and Don’ts”

DO take the pills at the same time every day, with or without food.
DO keep a daily log of your blood pressure.
DON’T stop taking the medicine or change your dose without asking your doctor.
DON’T ignore a severe headache; it could be a sign of very high blood pressure.

Legal Disclaimer

This guide is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Axitinib is a powerful prescription medicine that must be taken under the care of a specialist. Always consult your doctor before starting or stopping any medication. Individual results may vary based on your specific health history.